Results 71 to 80 of about 297,873 (128)

Incorporating historic information to further improve power when conducting Bayesian information borrowing in basket trials. [PDF]

Biostatistics
Daniells L, Mozgunov P, Barnett H, Bedding A, Jaki T.   +4 more
europepmc   +1 more source

Extreme Risk Protection Orders and Firearm and Nonfirearm Suicides in the US.

JAMA Health Forum
Brown TT, Kaplan MS, Yan Z, Xiao Y.
europepmc   +1 more source

Therapeutic Change May Begin before the Therapist and Patient Ever Meet: Pretreatment Alliance Changes Predict Clinical Outcomes. [PDF]

Psychother Psychosom
Zilcha-Mano S.
europepmc   +1 more source

Theoretical Considerations for Patient-Specific Modeling Based on Observable State Variables. [PDF]

J Biomech Eng
Ateshian GA, Deiters S, Weiss JA.
europepmc   +1 more source

Best practices for moving from correlation to causation in ecological research. [PDF]

Nat Commun
Correia HE, Dee LE, Byrnes JEK, Fieberg JR, Fortin MJ, Glymour C, Runge J, Shipley B, Shpitser I, Siegel KJ, Sugihara G, von Holle B, Ferraro PJ.   +12 more
europepmc   +1 more source

Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2-positive metastatic colorectal cancer. [PDF]

J Comp Eff Res
Watkins C, Simon C, Martin P, Leadley R, Redhead G, Neuberger E, Bartley K.   +6 more
europepmc   +1 more source

Informing the Borrowing Process for Dose-Finding Trials by Estimating the Similarity Between Population-Specific Dose-Toxicity Curves. [PDF]

Pharm Stat
Zocholl D, Götte H, Habermehl C, Günhan BK.   +3 more
europepmc   +1 more source

Optimal Finite Difference Angular Velocity Estimation for Spacecraft. [PDF]

J Astronaut Sci
Leo JP, Enright JP.
europepmc   +1 more source

Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials. [PDF]

ESMO Open
Jhaveri K, Bidard FC, Kalinsky K, Neven P, Rugo HS, Tolaney SM, Litchfield LM, von Laue CC, Traore S, Sapunar F, Li Y, O'Shaughnessy J.   +11 more
europepmc   +1 more source